Prestige BioPharma Limited (KRX:950210)
12,400
-120 (-0.96%)
At close: Oct 24, 2025
-0.96% (1Y)
| Market Cap | 149.04B |
| Revenue (ttm) | 14.33B |
| Net Income (ttm) | 22.30B |
| Shares Out | 12.02M |
| EPS (ttm) | 370.20 |
| PE Ratio | 33.50 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 96,314 |
| Average Volume | 134,983 |
| Open | 12,540 |
| Previous Close | 12,520 |
| Day's Range | 12,220 - 12,600 |
| 52-Week Range | 11,000 - 20,900 |
| Beta | 1.03 |
| RSI | 35.38 |
| Earnings Date | Sep 19, 2025 |